JSE-listed Clicks Group has released its Clicks interim results for the six months ending February 2025. They report impressive resilience and strategic accomplishments in the health and beauty retail sector. The group noted a 13.2% rise in headline earnings per share (HEPS). Clicks credits its robust earnings performance to several crucial factors. These include significant market share growth in its…
Tag: pharmacy
-
Clicks to sell stake in Unicorn Pharmaceuticals
The Clicks Group has announced plans to sell its shareholding in its pharmaceutical manufacturing subsidiary, Unicorn Pharmaceuticals. The sale is anticipated to be finalised by the end of July. This decision follows the Constitutional Court’s ruling in March 2023 in the Independent Community Pharmacy Association’s case against the Clicks Group case. Subsequently, the matter was referred to the director-general of…